CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Reconciliation of net income to cash provided by operating activities:
Net income	$ 87,209	$ 44,163
Add (deduct):
Depreciation and amortization	17,458	18,609
Provision for bad debt	889	510
Investment and other gains – net	(730)	(4,345)
Amortization of net premium on debt securities investments	3,790	4,617
Payments for title losses in excess of provisions	(11,266)	(1,106)
Adjustment for insurance recoveries of title losses	175	1,023
(Increase) decrease in receivables – net	(8,838)	2,020
Decrease (increase) in other assets – net	2,910	(406)
Increase (decrease) in accounts payable and other liabilities – net	6,753	(23,480)
Change in net deferred income taxes	5,563	(1,693)
Net income from equity investees	(1,996)	(1,344)
Dividends received from equity investees	1,964	2,187
Stock-based compensation expense	3,380	3,039
Other – net	28	(61)
Cash provided by operating activities	107,289	43,733
Investing activities:
Proceeds from sales of investments in securities	20,899	32,500
Proceeds from matured investments in debt securities	44,685	25,258
Purchases of investments in securities	(2,187)	(35,683)
Net purchases of short-term investments	(193)	(366)
Purchases of property and equipment, and real estate – net	(11,957)	(8,478)
Cash paid for acquisition of businesses	0	(17,639)
Other – net	2,111	327
Cash provided (used) by investing activities	53,358	(4,081)
Financing activities:
Payments on notes payable	(26,179)	(16,767)
Proceeds from notes payable	23,514	9,583
Distributions to noncontrolling interests	(8,578)	(8,665)
Contributions from noncontrolling interests	25	0
Repurchases of common stock	(481)	(687)
Cash dividends paid	(21,257)	(21,195)
Purchase of remaining interest in consolidated subsidiary	0	(1,102)
Cash used by financing activities	(32,956)	(38,833)
Effects of changes in foreign currency exchange rates	1,202	(1,229)
Increase (decrease) in cash and cash equivalents	128,893	(410)
Cash and cash equivalents at beginning of period	192,067	150,079
Cash and cash equivalents at end of period	$ 320,960	$ 149,669